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Abstract
Background: Vitamin D deficiency has been associated with acute stroke and other cardiovascular diseases in
the developed world. Low 25-hydroxyvitamin D (25OHD) has been described in some populations in Sub-Saharan
Africa (SSA) in spite of adequate sunshine all year round. There is no information on the magnitude of vitamin D
deficiency among patients with stroke and other cardiovascular diseases in Uganda or SSA. The aim of this study
was to determine the burden and characteristics of vitamin D deficiency among patients with acute stroke, the
most common form of cardiovascular events in SSA.
Methods: We conducted a cross-sectional study between October 2012 and March 2013. We consecutively recruited
142 subjects with acute stroke admitted to the medical wards of Mulago hospital. We administered a pre-tested
questionnaire to the study participants, and did a detailed physical examination and laboratory evaluation. Serum
levels of 25OHD were determined using an electrochemiluminescence assay. Data were analyzed using STATA
version 12 software.
Results: The prevalence of vitamin D deficiency (25OHD < 20 ng/ml) was 15 %. Longer hours of sunshine
exposure decreased the likelihood vitamin D deficiency significantly (adjusted OR 0.85, p = 0.03). Higher HDL
cholesterol had a significant inverse association with vitamin D deficiency (adjusted OR 0.15, p = 0.02). In
addition, the likelihood of vitamin D deficiency increased with rising age (adjusted OR 1.03, p = 0.05).
Conclusions: There was a relatively low burden of vitamin D deficiency among patients with acute stroke in
Uganda. With increasing longevity and indoor lifestyles vitamin D deficiency may assume a greater role in
stroke and other cardiovascular diseases in tropical sub Saharan Africa. Future studies on the mechanisms of
vitamin D deficiency and its relationship to outcomes among patients with stroke may be necessary.
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Background
Vitamin D deficiency is a widespread health problem, af-
fecting up to 1 billion people worldwide [1]. It has
gained increasing recognition in the developing world,
including Sub- Saharan Africa (SSA) where sunshine
prevails all year round [2–4]. Previous studies in SSA
have found widely varying prevalence of vitamin D defi-
ciency in a tropical region with good quality UVB radiation
[5–8]. For example, studies in Uganda which straddles the
equator have reported a prevalence of vitamin D deficiency
ranging between 9–20 % among healthy individuals [5, 6].
In central Ethiopia (80 33 N to 80 36 N) a prevalence of up
to 61 % has been reported among otherwise healthy urban
schoolchildren [8]. Latitude, season, cultural norms, reli-
gious practices, low awareness, low knowledge/health
literacy, indoor lifestyles, urban living, skin pigmentation,
malnutrition, diet, co-morbidities like tuberculosis, and
drugs may contribute to vitamin D deficiency in the SSA
region [2, 3, 9, 10].
* Correspondence: dchiggundu@gmail.com
1Department of Medicine, College of Health Sciences, Makerere University,
Kampala, Uganda
Full list of author information is available at the end of the article
© 2015 Kiggundu et al. Open Access This article is distributed under the terms of the Creative Commons Attribution 4.0
International License (http://creativecommons.org/licenses/by/4.0/), which permits unrestricted use, distribution, and
reproduction in any medium, provided you give appropriate credit to the original author(s) and the source, provide a link to
the Creative Commons license, and indicate if changes were made. The Creative Commons Public Domain Dedication waiver
(http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated.
Kiggundu et al. BMC Endocrine Disorders  (2015) 15:53 
DOI 10.1186/s12902-015-0053-y
Classically, vitamin D deficiency is known for its effects
on bone, causing reduced mineralization, rickets and osteo-
malacia [1, 3]. However, many new roles of vitamin D have
recently come to light, with more consequences attributed
to its deficiency [1]. Vitamin D deficiency is increasingly
associated with infectious diseases like tuberculosis and
severe malaria [6, 11, 12], and non communicable diseases
such as cancer, depression, dementia, multiple sclerosis,
cardiovascular diseases, and stroke [1, 6, 13–16].
Cardiovascular diseases are on the rise in SSA, where
they are projected to become the leading cause of
morbidity by 2030 [17]. Stroke contributes the biggest
proportion of cardiovascular disease in SSA and it is
responsible for up to 3 % of all adult deaths [17, 18].
Studies in non-tropical settings have described higher
burden of vitamin D deficiency among acute stroke
patients than non- stroke individuals in the same envir-
onment [16, 19]. Suboptimal vitamin D has been associ-
ated with many modifiable cardiovascular risk factors,
including physical inactivity, hypertension, dyslipidemia,
obesity and diabetes mellitus, including among migrant
populations from Sub Saharan Africa [13, 15, 20–23].
Furthermore, longitudinal studies have demonstrated
that vitamin D is an independent predictor of cardio-
vascular disease and stroke [13, 19]. The relationship
of vitamin D deficiency to large vessel stroke and
other atherosclerotic cardiovascular diseases may be
mediated by atherogenic proinflammatory cytokines
that foster atherosclerotic vascular changes and plaque
instability [24, 25].
Among stroke patients, vitamin D deficiency has been
shown to predict severity and adverse outcomes in-
cluding death [19, 26]. Stroke survivors with vitamin D
deficiency may be prone to bone loss and pathological
fractures [16, 26]. Supplementation with oral 25OHD
has been suggested as a potential strategy to reduce
cardiovascular diseases and other non-communicable
diseases [27]. Ongoing large scale clinical studies in
North America are evaluating the role of 25OHD re-
placement in the prevention of stroke among other non
communicable diseases [28].
Currently, there are few data on the magnitude of
vitamin D deficiency in patients with cardiovascular
diseases in tropical SSA with its unique latitude, indi-
genous peoples and culture. We therefore sought to
determine the prevalence and characteristics of vita-
min D deficiency in hospitalized patients with acute
stroke at Mulago national referral and teaching hos-
pital (Mulago hospital) in Kampala, Uganda.
Methods
Study design and site
This was a cross- sectional study conducted on the med-
ical wards of Mulago hospital from October 2012 to
March 2013. The medical wards receive 20–30 stroke
patients on the neurology service monthly [29]. Mulago
hospital is a 1600 bed- capacity hospital and it is the
largest referral hospital in Uganda. Uganda is located
on the East Africa plateau and spans the equator
from approximately 1°S to 4°N. Kampala city is
located near the equator at latitude of 00°20′North,
with constant sunshine all year round and two rainy
seasons; one from March to May and the other be-
tween September and December.
Study definitions and participants
For the purposes of this study, acute stroke was defined
as a stroke that had lasted not more than 2 weeks from
the onset of symptoms. Stroke diagnosis was made as
per the classical World Health Organisation definition
that identifies stroke as ‘a clinical syndrome typified by
rapidly developing signs of focal or global disturbance of
cerebral functions, lasting more than 24 h or leading to
death, with no apparent causes other than of vascular
origin’. Patients were included with or without radio-
logical confirmation using brain computerised tomog-
raphy (CT) scan.
A period within 2 weeks of symptoms was used to
designate acute stroke, in order to reflect pre-stroke
concentrations of 25OHD, with minimal post-stroke
influence. This was chosen because 25OHD has a half
life of 2–3 weeks,depending on 25OHD type and con-
centration, vitamin D binding protein genotype and con-
centration, and race [30].
The participants’ 25OHD status was defined basing
on the Endocrine Society Clinical Practice Guidelines
on evaluation, treatment and prevention of vitamin D
deficiency [31].
Normal 25OHD level was defined as serum
25OHD ≥ 30 ng/ml. Vitamin D insufficiency was defined
as serum 25OHD 20- < 30 ng/ml. Vitamin D deficiency
was used to describe 25OHD <20 ng/ml. That included
severe vitamin D deficiency with 25OHD <10 ng/ml.
During the study period, consecutive sampling was
used to approach all adults (aged ≥18 years) admitted to
the medical wards with a diagnosis of acute stroke made
by the ward team. Consent was obtained from patients
or their relatives, and patients who fulfilled the study
definition of acute stroke were consecutively enrolled
into the study. Patients for whom no history could be
obtained were excluded from the study.
Data collection
After obtaining informed consent, pre-tested question-
naires were administered by the study team to obtain
the socio-demographic characteristics, medical history
(history of hypertension, diabetes mellitus, HIV), drug
history (anti-convulsants, anti-retroviral therapy, multi-
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vitamin supplements, and anti tuberculous drugs), exer-
cise and estimated duration spent outdoors on a typical
day. HIV status was determined using a routine testing
and counselling algorithm of Mulago Hospital.
Diabetes mellitus (DM) status was decided by obtaining
history of a previous diagnosis of diabetes mellitus, or a
random glucose measurement ≥11.1 mmol/L. History of a
previous diagnosis of hypertension was obtained. Blood
pressure was measured using the Omron M2 Eco digital
blood pressure machine. Where the attending clinical
team reported a diagnosis of hypertension based on add-
itional clinical findings, it was accepted as part of the
history. However, due to the possibility of reactive changes
in blood pressure during acute stroke, blood pressure
measurements were not used to define hypertension. Lipid
profiles and blood glucose were measured without strict
observance of fasting state due to practical challenges in
enforcing fasting among often severely ill patients.
Waist circumference was measured to assess abdom-
inal obesity using the International Diabetes Federation
(IDF) criteria [32]. The participants’ Glasgow Coma
Scale (GCS) score and stroke type as identified on brain
CT scan were also documented (Additional file 1).
Laboratory assessment
Sample collection
From each participant, a blood sample (5 ml) was drawn
aseptically into a plain blood sample tube (BD Vacutainer)
and allowed to coagulate at room temperature.
The blood samples were transported to the clinical
chemistry laboratory of Mulago hospital within 1 h of
collection, centrifuged and the extracted sera stored
at −20 °C in a refrigerator until testing.
Diagnostic testing
Chemistry analysis was done on thawed sera, using the fully
automated COBAS® 6000 (Roche Diagnostics GmbH) ma-
chine. Serum 25OHD concentration was determined using
an electrochemilumniscence immunoassay: the Elecsys
Vitamin D Total assay (Roche diagnostics, Mannheim-
Germany; Reference number 05894913190 V4). It measures
total serum 25OHD concentrations in the range of
3–70 ng/ml. The COBAS 6000 analyzer was also used
to measure the serum lipids.
Measurement of albumin, calcium concentration, cre-
atinine and lipid profile was also done. (Lipid profile in-
cluded low density lipoprotein cholesterol [LDLC] and
high density lipoprotein cholesterol [HDLC].
Statistical analysis
Based on the prevalence of vitamin D deficiency (defined
as vitamin D levels < 20 ng/ml) of 9 % among healthy in-
dividuals in a study in Mulago Hospital, Kampala [5]
with a 95 % CI and desired precision of estimation of
0.05, a sample size of 126 patients was obtained. We en-
rolled 142 patients consecutively over a 6 months study
period; however, due to logistical constraints we did not
adjust sample size for associated factors.
Data were entered using Epi data entry version 3.1 and
exported to Stata version 12.1 software, for statistical
analysis. Patient characteristics were reported in tables
as proportions. Continuous variables were reported as
median and inter-quartile range (IQR). Relationship of
25OHD and continuous variables was explored with
Pearsons correlation coefficient.
With the study goal to identify characteristics asso-
ciated with vitamin D deficiency, factors were entered
into a logistic regression model. All statistically signifi-
cant factors from the univariate analysis with p < 0.1 were
entered into the multivariable logistic regres-
sion model. In addition, categorical outcomes that
were not binary were considered for inclusion if they
had a significant overall main effect. Important con-
founder variables including gender, diabetes mellitus,
central obesity and a history of hypertension were also
included in the model by a priori decision regardless
of statistical significance. A p-value of <0.05 and confi-
dence intervals not including 1 were considered to be
statistically significant at multivariable analysis.
Study approval
The study was approved by the Makerere University
College of Health Sciences, School of Medicine Research
and Ethics Committee. For all patients, written informed
consent was obtained prior to enrolment in the study from
their relatives or care takers. All participants were given in-
formation on the positive effect of exposure to sunshine on
25OHD levels. Where vitamin D deficiency was found, the
result was explained to the patient/caretaker by telephone,
with a recommendation to increase sunshine exposure
and/or oral 25OHD supplementation. The result was made
available to the medical clinic at routine follow up visits.
Results
Socio-demographic characteristics
Of the 168 patients screened, 142 patients were enrolled
consecutively. Among the 26 ineligible patients, an alter-
native diagnosis was found in 12 patients and no reliable
source of history was available for 12 others. For 2 pa-
tients, informed consent was not given. The response rate
was 91 % (142 of 156 patients with stroke). The overall
median age (interquartile range (IQR) of patients was 69
(50–70) years; predominantly females, 54 %; residing in
urban and peri-urban areas, 62 %; and had attended pri-
mary education, 61 % (Table 1). The median duration of
symptoms at enrolment was 5 days (IQR 3–7), and most
patients (90 % of 142) were enrolled within 10 days of on-
set of the symptoms.
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Clinical and laboratory findings
A previous history of hypertension was obtained in 75
patients (53 % of 142). Diabetes mellitus was found in 25
patients (19 % of 142); 19 patients by history of DM, and
an additional 6 patients based on a high random blood
glucose measurement. Other co-existing co-morbidities
were HIV infection, non-atrial fibrillation cardiac dis-
ease, atrial fibrillation and chronic kidney disease in 9, 6,
Table 1 Clinical characteristics associated with vitamin D deficiency among in-patients with acute stroke in Kampala
Uganda- bivariate analysis
Variable Total N (% of total) or
median (IQR)
25OHD <20 ng/ml n (% of row)
or median (IQR)
Crude odds ratio (OR) 95 % confidence interval P value
Gender
Male 69 (49) 12 (17) 1.00
Female 73 (51) 9 (12) 0.67 0.27–1.70 0.40
Hypertension history
No 67 (47) 7 (10) 1.00
Yes 75 (53) 14 (19) 1.97 0.74–5.21 0.17
Diabetes mellitus
No 117 (82) 18 (15) 1.00
Yes 25 (18) 3 (12) 0.73 0.20–2.72 0.64
HIV status
Negative 130 (92) 19 (15) 1.00
Positive 12 (8) 2 (17) 1.16 0.24–5.75 0.85
Previous Stroke
No 127 (89) 15 (12) 1.00
Yes 15 (11) 6 (40) 4.98 1.55–15.96 0.01
Typical dress
Gomesia 48 (34) 5 (10) 1.00
Short sleeve + trouser 33 (23) 7 (21) 2.32 0.67–8.05 0.19
Long sleeve + trouser 28 (20) 4 (14) 1.43 0.35–5.84 0.62
Other 33 (23) 5 (15) 1.54 0.41–5.79 0.53
Obesity
No 81 (57) 13 (16) 1.00
Yes 61 (43) 8 (14) 0.79 0.30–2.04 0.63
Stroke type
Ischemic 93 (76) 17 (18) 1.00
Hemorrhagic 30 (24) 2 (7) 0.32 0.27–1.70 0.14
bAge (years) 69 (50–70) 70 (62–79) 1.03 1.00–1.06 0.08
Daily time outdoors (h) 6.75 (3–10) 3 (1.5–7.5) 0.85 0.75–0.96 0.02
Exercise (days per week) 1 (0–7) 1 (0–7) 0.95 0.82–1.10 0.51
Systolic BP (mmHg) 155 (139–171.5) 150 (141–170) 1.00 0.98–1.01 0.58
Diastolic BP (mmHg) 90 (77–101.5) 90 (80–103) 1.00 0.98–1.01 0.71
Corrected Ca++ (mmol/l) 2.32 (2.22–2.39) 2.31 (2.23–2.36) 0.21 0.01–5.38 0.34
Random glucose (mmol/l) 6.7 (5.7–8.6) 6.7 (5.9–7.1) 1.09 0.91–1.30 0.33
Albumin (g/L) 37.4 (33.5–41.0) 36.6 (30.5–40.6) 0.93 0.86–1.01 0.07
Total cholesterol (mmol/L) 4.53 (3.59–5.45) 4.58 (3.18–5.4) 0.89 0.63–1.24 0.49
HDL cholesterol (mmol/L) 1.18 (0.94–1.43) 0.58 (1.31–1.15) 0.25 0.07–0.92 0.04
aUganda national women’s dress covering lower limbs and torso leaving arms bare
bData from this row onward are continuous; association with the categorical outcome of vitamin D deficiency is displayed as odds ratios
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4 and 3 % of the patients respectively. One patient had
sickle cell disease and one patient had tuberculosis.
Antiretroviral therapy was used by 5 of the 12 HIV
positive subjects, with majority (60 %) using an efavirenz
based regimen. The use of multivitamin supplements
was not found in any patient.
Prior history of stroke was reported in 15 (11 %) pa-
tients. A brain CT scan was done in 123 patients (87 %
of 142). However, 19 patients (13 % of 142) did not get
brain CT scans due to financial constraints. Ischemic
stroke was the most prevalent type of stroke, noted in
93 (76 %) patients.
The median HDL Cholesterol (HDLC) and total chol-
esterol (TC) in mmol/l was 1.18 (0.94–1.43), and 4.35
(3.59–5.45) respectively. The median calcium concentra-
tion, corrected for albumin levels in was 2.32 mmol/l
(1.99–2.59)
25OHD status and related factors
The prevalence of vitamin D deficiency was 15 % (21
out of 142 patients). This included 5 patients (4 % of 142)
who were categorized as having severe vitamin D defi-
ciency. Vitamin D insufficiency (25OHD 20- < 30 ng/ml)
was found in 29 patients (20 % of 142). Overall two thirds
(65 % of 142) of the study patients had adequate vitamin
D levels. The median (IQR) concentration of 25OHD was
36.4 ng/ml (22.0–45.7).
The burden of vitamin D deficiency was greater among
patients with ischemic stroke than in patients with
hemorrhagic strokes, although not statistically significant
(18 % vs. 7 %, p = 0.33). An age adjusted prevalence of
vitamin D deficiency by stroke type (computed using the
age distribution of the entire sample) was similar to the
crude prevalence, at 19 % versus 9 % in patients with
ischemic and hemorrhagic strokes respectively.
Among subjects with vitamin D deficiency, there were
more patients with a history of hypertension (n = 14,
67 % of 21) and more male patients (n = 12, 57 % of 21).
Vitamin D deficiency was found in 6 (29 % of 15) pa-
tients with a previous history of stroke, and 2 (17 % of
12) patients with HIV. None of the patients on antiretro-
viral therapy had vitamin D deficiency.
No significant linear relationship was observed between
25OHD and systolic blood pressure (r = −0.04, p = 0.62),
25OHD and diastolic blood pressure (r= −0.05, p = 0.58),
or 25OHD and random blood glucose (r = −0.03, p = 0.69).
At bivariate analysis, increasing age,, prior history of a
stroke, hours spent outdoors, increasing albumin and
HDLC concentrations had p values ≤ 0.1 and were entered
into the multivariate analysis model, Gender, diabetes
mellitus, obesity, and a history of hypertension were also
included as important confounders (Table 2). Lower
HDLC concentrations (OR 0.09, p = 0.02) and shorter dur-
ation outdoors (OR 0.83, p = 0.02) were independently
associated with vitamin D deficiency among stroke
patients in the multivariate analysis model. A previous
history of stroke (OR 3.8, p = 0.06) and increasing age
(OR 1.04, p = 0.05) were not significantly associated
with vitamin D deficiency.
Discussion
In this study, we found a relatively low prevalence of
vitamin D deficiency among adult in-patients with acute
stroke at a referral hospital in East Africa. The signifi-
cant factors associated with vitamin D deficiency in this
group were a lower reported duration of sunshine expos-
ure and lower HDL cholesterol. To our knowledge, this
study is the first in SSA to describe the burden of vita-
min D deficiency among patients with acute stroke or
other cardiovascular diseases.
Comparing studies that report vitamin D deficiency
requires attention to the 25OHD cut-off values used
to define it. Different cut-off values have been used
among studies in East African and elsewhere, ranging
from <10 ng/ml to <30 ng/ml [6, 31, 33, 34]. The
various cut-off values reflect the changing under-
standing of the roles of 25OHD beyond only bone
Table 2 Clinical characteristics associated with vitamin D






95 % CI P value
Gender
Male 1.00
Female 0.67 1.18 0.38–3.67 0.77
Diabetes
No 1.00
Yes 0.73 0.29 0.41–2.10 0.22
Obesity
No 1.00
Yes 0.79 0.71 0.21–2.37 0.57
Hypertension history
No 1.00
Yes 1.97 2.00 0.62–6.43 0.25
Previous stroke
No 1.00
Yes 4.98 3.80 0.94–15.32 0.06
aAge(years) 1.03 1.04 1.00–1.08 0.05
Daily time outdoors (h) 0.85 0.83 0.71–0.97 0.02
Albumin (g/L) 0.93 1.01 0.90–1.13 0.92
HDL cholesterol 0.25 0.09 0.01–0.68 0.02
aFrom this row onwards, continuous predictor variables are displayed, with
odds ratio of vitamin D deficiency per unit rise in the predictor variable
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health, to include roles in immunology and infections,
mental illness, cardiovascular prevention, cancer, and
other health outcomes [1, 12, 24, 25, 33, 35]. A cut-
off value of <20 ng/ml is widely accepted through
consensus among experts [1, 31, 33]. It is also fre-
quently reported even by studies that define vitamin
D deficiency otherwise. For purposes of this study, we
took care to compare 25OHD <20 ng in reference to
vitamin D deficiency.
Our findings on the prevalence of vitamin D deficiency
are similar to those in other studies in the region of
SSA: in Uganda this prevalence has been 9–20 % among
normal study subjects [5, 6]. Among in-patients on a
medical ward in Malawi a prevalence of 14 % was found
[36]. However, an examination of data from other stud-
ies reveals wide contrasts in the SSA region: among
traditionally living populations in East Africa have re-
ported a high mean 25OHD value with virtually no vita-
min D deficiency [37]. In contrast, studies in central
Ethiopia and Northern Nigeria have reported high
prevalence of suboptimal 25OHD levels [7, 8].
We found that lower sunshine exposure was associ-
ated with vitamin D deficiency in this study. This is
expected since ultraviolet B (UVB) radiation in sun-
shine drives cutaneous vitamin D synthesis [1]. Esti-
mating exposure to sunshine using a questionnaire to
establish typical intervals spent outdoors is a method
that has been used with some success, but it is limited
by recall bias and variation in behaviour during time
spent outdoors [38].
The association between older age and vitamin D defi-
ciency was not statistically significant, probably due to
the limited sample size and study power. An association
between rising age and vitamin D deficiency was the ex-
pected; it is biologically plausible due to a decline in the
efficiency of cutaneous vitamin D synthesis with increas-
ing age [1, 39]. Paradoxically, another recent study in an
urban population in East Africa reported lower levels of
25OHD among younger adults compared to older adults
[40]. This may reflect changing lifestyles and decreased
sunshine exposure among younger urban populations.
Other factors including, religion, cultural practices, diet,
co-morbidities and low awareness may contribute to dis-
parities in the prevalence of vitamin D deficiency seen in
the tropics [2, 3]. Genotype of vitamin D binding protein
and the type of 25OHD (25OHD2 or 25OHD3) are linked
to changes in the serum half life of vitamin D deficiency
and the likelihood of vitamin D deficiency [30].
Outside the tropics, studies among patients with
acute stroke/cardiovascular events generally report
greater prevalence of vitamin D deficiency than we
found. In Europe and South East Asia, studies also re-
port a greater burden of vitamin D deficiency among
stroke patients compared to control subjects in the
same environment [16, 41]. Our study design did not
include similar control subjects, limiting our ability to
make meaningful comparisons.
Among patients with stroke vitamin D deficiency is re-
ported to predict greater severity and adverse outcomes
including recurrent strokes and death [26, 42]. Vitamin
D deficiency is also linked with a greater likelihood of
falls, poor muscle and bone health, and possibly in-
creased fracture risk among stroke survivors [16, 43].
On the other hand stroke predisposes to vitamin D defi-
ciency, possibly through reduced dietary intake, inability
to feed independently, and decreased mobility and sun-
shine exposure [16, 43]. As expected, we found a higher
burden of vitamin D deficiency among the subjects who
had suffered at least one previous stroke. Nonetheless,
no significant association was found after adjusting for
other factors perhaps due to low study power. However,
we did not examine the relation of 25OHD status with
stroke severity or mortality in our setting. Routine strat-
egies to prevent vitamin D deficiency among stroke sur-
vivors in our setting are required.
While vitamin D deficiency is an independent pre-
dictor for stroke and other cardiovascular events, it is
also associated with traditional risk factors like hyperten-
sion, insulin resistance/diabetes, obesity, abnormal lipid
profile [24, 44]. Our study indeed showed that the likeli-
hood of vitamin D deficiency increased with a declining
HDL level. Studies among immigrants from SSA in
Australia have documented vitamin D deficiency clus-
tered with obesity, insulin resistance and dyslipidemia
[23], and go ahead to propose a role for vitamin D re-
placement in cardiovascular prevention [27]. In addition,
vitamin D deficiency is related to novel cardiovascular
risk factors such as C-Reactive Protein and pro-
inflammatory cytokines [24, 44]. We were not able to
demonstrate an association between vitamin D defi-
ciency and hypertension-the single most powerful car-
diovascular risk factor in SSA today [18].
Importantly the diagnosis of hypertension and diabetes
in our study were influenced by low awareness of either
condition, physiological responses of blood pressure and
blood sugar to acute stroke [45], and absence of support-
ing tests like the HBA1c assay.
In this region with rising incidence of cardiovascular
risk factors and diseases, vitamin D deficiency appears to
contribute a minor fraction to the burden at present.
The burden of vitamin D deficiency in relation to
stroke/cardiovascular diseases may increase with greater
longevity, and behavioural change including lower ex-
posure to sunshine.
Limitations
Due to logistical constraints, low numbers were recruited
in our study, thus limiting the power of the study. The
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diagnosis of acute stroke was made based on clinical his-
tory and physical exam findings within 2 weeks of onset,
with or without corroborating imaging studies. While this
could limit the accuracy of stroke diagnosis, similar ap-
proaches have been used in other studies on stroke and
vitamin D deficiency. We included all stroke subtypes in
this study. Previous studies have not always made a dis-
tinction between hemorrhagic and ischemic strokes.
Mechanisms by which vitamin D deficiency is related to
stroke relate more to atherosclerosis and ischemic stroke.
Different 25OHD assays were used in the studies we
have compared, but the new Roche vitamin D total assay
that we used has demonstrated strong correlation with
high performance liquid chromatography/mass spectrom-
etry and established radioimmunoassay techniques [46].
Due to our study design, we are unable to show a tem-
poral relationship between vitamin D deficiency and
stroke events. However, studies elsewhere have frequently
found that vitamin D deficiency is associated with stroke,
and may indeed predict stroke [19]. Ongoing studies else-
where are investigating the role of 25OHD replacement
on non communicable diseases including cardiovascular
disease, cerebrovascular disease and cancer [28].
Conclusions
There was a relatively low burden of vitamin D defi-
ciency among patients with acute stroke in Uganda.
Vitamin D deficiency plays a minor role in stroke risk in
Uganda at present. With increasing longevity and indoor
lifestyles vitamin D deficiency may assume a greater role
in stroke and other cardiovascular diseases in tropical
sub Saharan Africa. Future studies may be necessary to
evaluate the relationship of vitamin D deficiency to
stroke outcomes and the mechanisms thereof.
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